Celgene obtains dismissal in Washington product liability action
Clients Celgene Corporation
Jones Day, on behalf of Celgene Corporation, obtained a dismissal of a product liability suit against a host of drug and medical device manufacturers stemming from alleged heparin-induced thrombocytopenia or "HIT".
McFarland v. APP Pharmaceuticals, LLC, et al., Case No. 2:10-CV-01746 (W.D. Wash.)